Delivery Order SPE2DB22D3019-SPE2DB25FK3NF
Award Date
4/25/25
Potential Completion Date
4/28/25
Potential Value
$8.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB24D2205|SPE2DB25FEBRF, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,518.70 firm fixed-price delivery order is for 4,568,076,830 units of the prescription medication Vyvanse 30 mg capsules. The contract has an ultimate completion date of April 30, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, with ID SPE2DB20D2014|SPE2DB25FB63L, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,620.22 firm fixed-price delivery order is for the supply of 4,567,939,735 units of the medication Vyvanse 30 mg capsules. The contract has an ultimate completion date of April 16, 2025 and was awarded on April 15, 2025. This delivery order is part of a larger Indefinite...
This federal contract award, with ID SPE2DB22D3301|SPE2DB25FY2NZ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,833.58 firm fixed-price delivery order is for the supply of 4,567,781,802 units of the medication Vyvanse 30 mg capsules. The contract has an ultimate completion date of April 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This federal contract award, with the ID SPE2DB22D3004|SPE2DB25FPJ94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,857.45 Firm Fixed Price contract is a Delivery Order for the supply of 4,567,149,641 units of the prescription medication Vyvanse 30 mg capsules. The contract has an ultimate completion date of February 5, 2025. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,809.54 firm-fixed-price delivery order is for 4,556,517,806 units of the medication Vyvanse 30 mg capsules. The contract has an ultimate completion date of March 10, 2022 and was awarded on March 9, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award, valued at $3,567.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vyvanse 30 mg capsules. The contract is a firm fixed-price delivery order with an ultimate completion date of April 16, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with ID SPE2DB22D1200|SPE2DB25FM9KG, is a Delivery Order placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,566.51 Firm Fixed Price contract is for the supply of 4,566,655,068 units of the prescription medication Vyvanse 60 mg capsules. The contract has an ultimate completion date of December 10, 2024 and was awarded on December 9, 2024. This award is a component of a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,296.22 firm fixed-price delivery order is for the supply of 4,566,498,336 units of Vyvanse 30 mg capsules. The contract has an ultimate completion date of November 21, 2024 and was awarded on November 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, with ID SPE2DB20D1051|SPE2DB25FD7XJ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,152.11 firm fixed-price delivery order is for the supply of 4,568,078,136 units of the prescription medication Vyvanse 30 mg capsules. The contract has an ultimate completion date of April 30, 2025. This award is not associated with a set-aside and appears to be part of a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,586.00 firm fixed price delivery order is for the supply of 4,566,150,315 units of the prescription drug Vyvanse 50 mg capsules. The contract has an ultimate completion date of October 21, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...